Rapid Construction of Tissue-engineered Skin for Repairing Difficult-to-heal Wounds
Rapid Construction of Tissue-engineered Skin for Repairing Difficult-to-heal Wounds: A Multicenter Real-world Study
研究概览
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Hu Zhicheng
- 电话号码:87755766-8265
- 邮箱:huzhch5@mail.sysu.edu.cn
学习地点
-
-
Guangdong
-
Guangzhou、Guangdong、中国
- 招聘中
- The First Affiliated Hospital of Sun Yat-sen University
-
接触:
- The First Affiliated Hospital of Sun Yat-sen University
- 电话号码:87755766-8265
- 邮箱:huzhch5@mail.sysu.edu.cn
-
-
参与标准
资格标准
适合学习的年龄
- 孩子
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- All-age population
Wounds requiring surgical repair (single area 10-100 cm²): acute wounds (burns, traumatic defects, post-scar resection) OR chronic wounds (diabetic foot ulcers, pressure injuries, vascular ulcers)
Completed wound bed preparation (no necrotic tissue, infection controlled)
Signed informed consent and agreement to use tissue-engineered materials and long-term follow-up
Exclusion Criteria:
- History of allergy to allogeneic/xenogeneic tissue-engineered scaffolds or collagen materials
Severe immunosuppression (HIV/AIDS, long-term immunosuppressant use)
Malignant tumors, uncontrolled systemic infection (CRP > 50 mg/L), or organ failure (Child-Pugh Class C)
Mental illness preventing compliance with treatment or follow-up
Pregnant or lactating women
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:非随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Rapid Tissue-Engineered Skin Group
Rapid intraoperative construction of autologous EpiSCs-loaded scaffold + split-thickness skin graft (one-step or two-step procedure)
|
Autologous split-thickness skin (0.15-0.2 mm) is harvested from the donor site at a donor-to-wound area ratio of 1:20-30.
The harvested skin is processed using a specialized cell sorter to isolate autologous epidermal stem cells (EpiSCs) with >93% viability within 30 minutes.
The cell suspension is adjusted to a concentration of ≥1×10⁶ cells/mL and loaded onto a tissue-engineered scaffold via spraying or immersion (3-5 minutes).
The cell-seeded scaffold is then applied to the wound bed.
Depending on wound condition: (1) One-step procedure: scaffold and a split-thickness skin graft (0.15-0.2 mm) are applied simultaneously; (2) Two-step procedure: scaffold is implanted first, followed by split-thickness skin graft at 14±3 days post-primary surgery.
Negative pressure wound therapy (-100 to -125 mmHg) is applied as needed.
|
|
有源比较器:Traditional Composite Skin Graft Group
|
The same tissue-engineered scaffold (without cell loading) is used.
Autologous split-thickness skin graft (0.15-0.2 mm thickness) is harvested.
The acellular scaffold is applied to the debrided wound bed followed by coverage with the split-thickness skin graft.
The surgical procedure, postoperative wound care, negative pressure wound therapy (-100 to -125 mmHg when indicated), and follow-up protocol are identical to those in the experimental arm.
This comparator represents the current standard of care for composite skin grafting in the participating centers.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Complete Wound Healing Rate
大体时间:At 4 weeks post-surgery
|
The percentage of participants achieving complete wound epithelialization (defined as 100% re-epithelialization without drainage or dressing requirements)
|
At 4 weeks post-surgery
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Wound Recurrence Rate
大体时间:3, 6, 12 months post-surgery
|
Incidence of wound recurrence at the healed site
|
3, 6, 12 months post-surgery
|
|
Scar Quality Assessment
大体时间:4 weeks, 3, 6, 12 months post-surgery
|
Scar quality is assessed using the Vancouver Scar Scale (VSS) and the Patient and Observer Scar Assessment Scale (POSAS) at 4 weeks, 3, 6, and 12 months post-surgery.
The VSS total score ranges from 0 to 13, with higher scores indicating worse scar outcome (assessing vascularity, pigmentation, pliability, and height).
The POSAS includes two separate subscales: the Observer Scale (6 items, each scored 1 to 10, total range 6-60) and the Patient Scale (6 items, each scored 1 to 10, total range 6-60).
For both POSAS subscales, higher scores represent worse scar outcome.
|
4 weeks, 3, 6, 12 months post-surgery
|
|
Functional Recovery
大体时间:6, 12 months post-surgery
|
Sweat test for assessment of sweat gland regeneration
|
6, 12 months post-surgery
|
|
Mortality Rate
大体时间:3, 6, 12 months post-surgery
|
All-cause mortality
|
3, 6, 12 months post-surgery
|
|
Amputation Rate
大体时间:3, 6, 12 months post-surgery
|
Incidence of amputation (for chronic wound patients)
|
3, 6, 12 months post-surgery
|
|
Healing Trajectory
大体时间:1, 2, 3 weeks post-surgery
|
Wound healing rate at week 1, 2, 3; and time to complete healing
|
1, 2, 3 weeks post-surgery
|
|
Safety Outcome
大体时间:From day of surgery through 12 months post-surgery
|
Safety outcome is the incidence of postoperative complications (including infection, hematoma, and graft failure), adverse events, and serious adverse events, assessed from the day of surgery through study completion, an average of 12 months.
|
From day of surgery through 12 months post-surgery
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 2026P-ZD025
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.